Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Based on the creator's niche and the "Human Dominance" Discord branding, this video almost certainly falls into the performance optimization genre that's exploded on peptide TikTok. Creators in this space typically stack claims about BPC-157 accelerating tendon repair, TB-500 rebuilding tissue at near-supernatural speed, and growth hormone secretagogues like CJC-1295 or ipamorelin "optimizing" body composition without the legal baggage of actual HGH. The framing tends to be aspirational and bro-science adjacent, leaning on words like "biohacking" and "unlocking" human potential. The technology and engineering hashtags suggest the creator may be positioning peptides as a kind of human software update, which sounds compelling and is also where the scientific evidence gets very thin very fast.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and most human data is embarrassingly sparse. BPC-157 has shown genuine promise in rat and rodent models for gastric ulcer healing and tendon repair, but as of 2024 there are zero completed randomized controlled trials in humans (Sikiric et al., 2018, Current Pharmaceutical Design). TB-500, a synthetic fragment of thymosin beta-4, showed some cardiac repair potential in preclinical models but human data is essentially nonexistent. CJC-1295 combined with ipamorelin does measurably elevate IGF-1 levels, with one study showing roughly a 2-fold increase in growth hormone pulse amplitude (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism), but what that translates to in terms of meaningful clinical outcomes for healthy adults remains poorly defined. GHK-Cu has legitimate wound-healing literature behind it mostly in topical applications. The gap between rodent data and human benefit is where almost every peptide hype cycle quietly dies.

Where does the social media noise diverge from clinical reality?

The biggest divergence is the certainty. Peptide TikTok presents these compounds as established therapeutics when most are research chemicals with no FDA approval for the uses being discussed. BPC-157 is not approved by the FDA and was placed on the FDA's list of substances that cannot be compounded under Section 503A or 503B, meaning licensed compounding pharmacies in the US cannot legally produce it for patient use. Creators rarely mention this. They also rarely mention that injectable peptides purchased from gray-market research chemical suppliers carry real contamination risks, variable purity, and zero pharmacovigilance. A 2020 analysis published in Drug Testing and Analysis found significant dosing inaccuracies in commercially available peptide products. The performance gains described in these videos, such as healing injuries in two weeks or dramatically improving body composition, are not supported by any controlled human trial at any dose.

What should you actually know?

Some peptides in this category have legitimate, regulated medical applications. Ipamorelin and CJC-1295 are prescribed by licensed physicians for adult growth hormone deficiency in some contexts, and MK-677 (ibutamoren) is still being studied in clinical trials for muscle wasting conditions. GHK-Cu has reasonable topical data. Semax and selank have some Russian clinical literature behind them, though it is limited and difficult to independently verify. The problem is not that peptides are universally useless. The problem is that the claims being made online almost always outrun the available evidence by a significant margin, the sourcing of these compounds is often unregulated, and the framing as consequence-free optimization tools ignores real risks including suppression of endogenous hormone axes with secretagogues and unknown long-term safety profiles across nearly all of these compounds. Talk to a board-certified physician before considering any of this.